Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine
NCT00995332
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Acute Myelogenous Leukemia
Interventions
DRUG:
Cytarabine, all-trans retinoic acid, valproic acid
Sponsor
University of Bergen